APA (7th ed.) Citation

Lygate, C., Hulbert, K., Monfared, M., Cole, M., Clarke, K., & Neubauer, S. (2003). The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.

Chicago Style (17th ed.) Citation

Lygate, C., K. Hulbert, M. Monfared, M. Cole, K. Clarke, and S. Neubauer. The PPARgamma-activator Rosiglitazone Does Not Alter Remodeling but Increases Mortality in Rats Post-myocardial Infarction. 2003.

MLA (9th ed.) Citation

Lygate, C., et al. The PPARgamma-activator Rosiglitazone Does Not Alter Remodeling but Increases Mortality in Rats Post-myocardial Infarction. 2003.